Pattern of weight changes in women with breast cancer. by Yong, Heng Yaw, Kandiah, Mirnalini, Mohd Shariff, Zalilah, Chan, Yoke Mun, Hashim, Zailina, Mohd Yusof, Rokiah, Othman, Zabedah, Saibul, Nurfaizah, Yong, Heng Weay

“…However, no significant difference in weight change by educational level, family history of cancer and cancer stages were observed in all 3 periods. In conclusion, significant weight gain was evident in this sample of women after diagnosis of breast cancer and treatment. …”
Get full text

2317 Uterine serous carcinoma is associated with a high risk of venous thromboembolism regardless of latency from surgical staging by Gregory M. Gressel, Lauren Turker, Shayan Dioun, Nicole S. Nevadunsky

“…Cox proportional hazard modeling revealed that after adjustment for other covariates, only cancer stage and the presence of cardiovascular disease were significantly associated with time to failure. …”
Get full text

Assessment of Narrow-Band Imaging Algorithm for Video Capsule Endoscopy Based on Decorrelated Color Space for Esophageal Cancer: Part II, Detection and Classification of Esophageal... by Yu-Jen Fang, Chien-Wei Huang, Riya Karmakar, Arvind Mukundan, Yu-Ming Tsao, Kai-Yao Yang, Hsiang-Chen Wang

“…The NBI model effectively enhanced both its recall and accuracy rates in detecting dysplasia cancer, a pre-cancerous stage that might improve the overall five-year survival rate. …”
Get full text

Patient‐reported quality of life in adolescents and young adults with cancer who received radiation therapy by Kelsey L. Corrigan, Bryce B. Reeve, John M. Salsman, Elizabeth J. Siembida, Grace L. Smith, Maria C. Swartz, Kamaria L. Lee, Faraz Afridi, Lauren M. Andring, Andrew J. Bishop, Jillian R. Gunther, J. Andrew Livingston, Susan K. Peterson, Michael Roth

“…Conclusions AYAs with cancer receiving RT experience impairments in various domains of HRQOL. Advanced cancer stage may contribute to poorer short‐term HRQOL and developmental stage may contribute to differing long‐term HRQOL.…”
Get full text

Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer by J. Lluch-Gómez, V. Núñez-Álvarez, C. de la Torre-Hita, M. Bernal-Gómez, A. Campini-Bermejo, E. Perdomo-Zaldívar, L. Rodríguez-Pérez, J. Calvete-Candenas, M. J. Martínez-Bautista, E. Benítez-Rodríguez, J. M. Baena-Cañada

“…Observational, retrospective study of patients with HER2+ breast cancer, stages I–III, treated with adjuvant trastuzumab in the past 15 years in only one center and for the first time in Spain. …”
Get full text

Angiogenesis regulators S100A4, SPARC and SPP1 correlate with macrophage infiltration and are prognostic biomarkers in colon and rectal cancers by Elena Kazakova, Elena Kazakova, Militsa Rakina, Militsa Rakina, Tatiana Sudarskikh, Pavel Iamshchikov, Pavel Iamshchikov, Anna Tarasova, Liubov Tashireva, Sergei Afanasiev, Alexei Dobrodeev, Lilia Zhuikova, Nadezhda Cherdyntseva, Nadezhda Cherdyntseva, Nadezhda Cherdyntseva, Julia Kzhyshkowska, Julia Kzhyshkowska, Julia Kzhyshkowska, Julia Kzhyshkowska, Irina Larionova, Irina Larionova, Irina Larionova

“…Currently, available prognostic factors largely include clinical-pathological parameters and focus on the cancer stage at the time of diagnosis. Among cells of tumor microenvironment (TME) only Immunoscore classifier based on T lymphocytes showed high predictive value.MethodsIn the present study, we performed the complex analysis of mRNA and protein expression of crucial regulators of tumor angiogenesis and tumor progression, expressed by tumor-associated macrophages (TAMs): S100A4, SPP1 and SPARC. …”
Get full text

Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms by Austin M. Eckhoff, Michael C. Brown, Karenia Landa, Ibtehaj Naqvi, Eda K. Holl, David Boczkowski, Ashley Fletcher, Kristen E. Rhodin, Minh Huy Giang, Bruce Sullenger, Georgia M. Beasley, Peter J. Allen, Smita K. Nair, Smita K. Nair, Smita K. Nair

“…Serum from patients with IPMN and PDAC recapitulated suppression of TNF induction after R848 stimulation in naïve, healthy donor monocytes.ConclusionPeripheral blood monocyte TNF secretion inversely correlates with the degree of dysplasia in IPMN and cancer stage in PDAC, suggesting innate immune reprogramming as IPMNs progress to invasive disease. …”
Get full text

A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn score by Lucy A. Norris, Mark P. Ward, Sharon A. O'Toole, Zibi Marchocki, Nadia Ibrahim, Ali S. Khashan, Feras Abu Saadeh, Noreen Gleeson

“…Following competing risk regression analysis, subdistribution hazard ratios (SHRs), adjusted for cancer stage, were 8.16 (95% confidence interval [CI], 1.69‐43.77) in the high‐risk group (score = 2‐3) and 4.12 (95% CI, 0.85‐20.15) in the intermediate‐risk group (score = 1) compared with the low‐risk group (score = 0). …”
Get full text

Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy by Long-Hai Feng, Long-Hai Feng, Yu-Yao Zhu, Jia-Min Zhou, Jia-Min Zhou, Miao Wang, Miao Wang, Wei-Qi Xu, Wei-Qi Xu, Ti Zhang, Ti Zhang, An-Rong Mao, An-Rong Mao, Wen-Ming Cong, Hui Dong, Lu Wang, Lu Wang

“…There were differences in transfusion, Barcelona Clinic Liver Cancer stage and tumor-node-metastasis stage in the EHBH cohort. …”
Get full text

Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan by Tsutomu Yoshida, Go Ogura, Mikiko Tanabe, Takuo Hayashi, Chiho Ohbayashi, Mizutomo Azuma, Chikara Kunisaki, Yoichi Akazawa, Soji Ozawa, Sohei Matsumoto, Takayoshi Suzuki, Akira Mitoro, Tetsu Fukunaga, Akiko Shimizu, Go Fujimoto, Takashi Yao

“…This multicenter (5 sites), retrospective, observational study (November 2018–March 2019) evaluated Japanese patients with advanced gastric and GEJ adenocarcinoma after surgical resection (Stage II/III at initial diagnosis) or unresectable advanced cancer (Stage IV). The primary objectives were prevalence of PD-L1 expression (combined positive score [CPS] ≥1), MSI status, and EBV positivity. …”
Get full text

Survival of patients with salivary gland malignancies depending on the molecular profile of the tumor by S. I. Kutukova, E. N. Imyanitov, G. A. Raskin, Yu. V. Ivaskova, N. P. Belyak, A. I. Yaremenko, A. Ya. Razumova, P. M. Baykalova

“…Fifty-nine patients with a confirmed diagnosis of salivary gland cancer (stages II–IVA) were examined in the period from 2012 to 2014 at Saint Petersburg City Clinical Oncology Dispensary. …”
Get full text

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer by Hyungseok Cho, Cheol Kyu Oh, Jiwon Cha, Jae Il Chung, Seok-Soo Byun, Sung Kyu Hong, Jae-Seung Chung, Ki-Ho Han

“…Results: PSA mRNA expression in CTCs was observed in 30% (9/30) of patients with localized cancer, 60.0% (6/10) among patients with mHSPC, 65.3% (49/75) among patients with mCRPC, and 0% among patients with HD, indicating that the detection rate of PSA mRNA increased with cancer stage. PSA mRNA expression in CTCs also increased from localized to metastatic stages. …”
Get full text

Combined and expanded operations in patients with relapsed ovarian cancer and affected retroperitoneal lymph nodes by Kh. I. Mamazhonov, S. O. Nikogosyan, V. V. Kuznetsov, A. S. Shevchuk, O. A. Egenov

“…This retrospective study included patients with recurrent ovarian cancer stage I–IV less than 80 years of age who was treated in the Department of Gynecologic Oncology, N. …”
Get full text

Dickkopf-Related Protein 1 as Response Marker for Transarterial Chemoembolization of Hepatocellular Carcinomas by Anne Olbrich, Olga Gros, Sebastian Ebel, Timm Denecke, Holger Gößmann, Nicolas Linder, Florian Lordick, Dirk Forstmeyer, Daniel Seehofer, Robert Sucher, Sebastian Rademacher, Johannes Niemeyer, Madlen Matz-Soja, Thomas Berg, Florian van Bömmel

“…DKK-1 levels were lower in patients with liver cirrhosis (<i>p</i> = 0.002) and showed a strong correlation with total radiologic tumor size (r = 0.593; <i>p</i> < 0.001) and with Barcelona Clinic Liver Cancer stages (<i>p</i> = 0.032). Median DKK-1 levels were significantly higher in refractory patients as compared to responders (1471 pg/mL [range, 546–2492 pg/mL] versus 837 pg/mL [range, 199–4515 pg/mL]; <i>p</i> < 0.001), and DKK-1 could better identify responders than AFP (AUC = 0.798 vs. …”
Get full text

Conserved methylation signatures associate with the tumor immune microenvironment and immunotherapy response by Qingqing Qin, Ying Zhou, Jintao Guo, Qinwei Chen, Weiwei Tang, Yuchen Li, Jun You, Qiyuan Li

“…We correlated DNA methylation signatures with various clinical and biological features, including age, survival, cancer stage, tumor immune microenvironment factors, and immunotherapy response. …”
Get full text

Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China by Zhao Wu, Lifeng Cui, Junlin Qian, Laihui Luo, Shuju Tu, Fei Cheng, Lebin Yuan, WenJian Zhang, Wei Lin, Hongtao Tang, Xiaodong Li, Hui Li, Yang Zhang, Jisheng Zhu, Yong Li, Yuanpeng Xiong, Zemin Hu, Peng Peng, Yongzhu He, Liping Liu, Kun He, Wei Shen

“…Among the different levels of risk factors affecting prognosis [AFP, Lymphocyte-to-monocyte ratio, Maximum tumor diameter, Number of tumors, Child-Pugh classification, Liver cirrhosis, Vascular invasion (imaging), Microvascular invasion, Satellite nodules, Differentiation, Chinese liver cancer stage II-IIIa], the majority of patients who received adjuvant TACE had higher DFS or OS than those who did not receive adjuvant TACE. …”
Get full text

Effect of a 1-year tailored exercise program according to cancer trajectories in patients with breast cancer: study protocol for a randomized controlled trial by Jiin Ryu, Eun-Young Lee, Jihee Min, Sujin Yeon, Ji-Won Lee, Sang Hui Chu, Hyangkyu Lee, Seung Il Kim, Jee Ye Kim, Seho Park, Justin Y. Jeon

“…Abstract Background Patients with breast cancer undergo various treatments according to their tumor subtype and cancer stages within 1 year after being diagnosed. Each treatment may cause treatment-related symptoms that have negative impacts on patients’ health and quality of life (QoL) The symptoms can be mitigated when exercise interventions are appropriately applied to patients’ physical and mental conditions. …”
Get full text

Health-related quality of life and associated factors among cancer patients in Ethiopia: Systematic review and meta-analysis. by Tadele Lankrew Ayalew, Belete Gelaw Wale, Kirubel Eshetu Haile, Bitew Tefera Zewudie, Mulualem Gete Feleke

“…Furthermore, average monthly income, cancer stage, physical, and social functioning were all significant determinants in cancer patients' QOL.as a result, this review suggests that quality of life evaluation be incorporated into a patient's treatment routine, with a focus on linked components and domains, as it is a critical tool for avoiding and combating the effects of cancer and considerably improving overall health. …”
Get full text

The Overall Quality of Life and Oncological Outcomes Following Radical Hysterectomy in Cervical Cancer Survivors Results from a Large Long-Term Single-Institution Study by Mihai Stanca, Dan Mihai Căpîlna, Cristian Trâmbițaș, Mihai Emil Căpîlna

“…The first objective is to evaluate the OS rates of patients with cervical cancer stages IA2 to IIB undergoing radical hysterectomy (RH) +/− neoadjuvant or adjuvant radiotherapy +/− chemoradiotherapy treatment combinations. …”
Get full text

Construction and evaluation of a cloud follow-up platform for gynecological patients receiving chemotherapy by Xin Dan, Ya-Lin He, Yan Huang, Jian-Hua Ren, Dan-Qing Wang, Ru-Tie Yin, Ya-Lin Tian

“…Results General information, including age, education attainment, cancer stage, and disease category, and follow-up rate (cloud: 6,957/7,614, 91.4%; manual: 1,869/2,070, 90.3%; P = 0.13) did not significantly differ between the two groups. …”
Get full text